Acorda Therapeutics Inc RSI
Was ist das RSI von Acorda Therapeutics Inc?
RSI von Acorda Therapeutics Inc ist 15.87
Was ist die Definition von RSI?
Der relative Stärke-Index (RSI 14) ist ein Momentumindikator, der die Größe von Gewinnen und Verlusten über einen bestimmten Zeitraum vergleicht, um die Geschwindigkeit und die Änderung von Preisbewegungen eines Wertpapiers zu messen.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Acorda Therapeutics Inc
Was macht Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Unternehmen mit rsi ähnlich Acorda Therapeutics Inc
- Starboard Value Acquisition hat RSI von 15.76
- Ocean Agro (India) hat RSI von 15.80
- Qutoutiao Inc hat RSI von 15.85
- True Leaf Brands hat RSI von 15.86
- China Leasing hat RSI von 15.86
- Subversive Real Estate Acquisition REIT LP hat RSI von 15.86
- Acorda Therapeutics Inc hat RSI von 15.87
- Wildpack Beverage hat RSI von 15.89
- Healthcare Merger hat RSI von 15.92
- Bpost S.A. Compartment A hat RSI von 15.94
- Premia ETF Series - Premia CSI Caixin China Bedrock Economy ETF hat RSI von 15.94
- Trio Industrial Electronics hat RSI von 15.96
- Mortgage Advice Bureau () Plc hat RSI von 15.97